APEXIGEN Trademark

Trademark Overview

On Monday, August 23, 2010, a trademark application was filed for APEXIGEN with the United States Patent and Trademark Office. The USPTO has given the APEXIGEN trademark a serial number of 85114062. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, December 31, 2022. This trademark is owned by Apexigen, Inc.. The APEXIGEN trademark is filed in the Computer & Software Services & Scientific Services, Personal and Legal & Social Services categories with the following description:

licensing of intellectual property in the fields of therapeutics and pharmaceuticals

consulting services in the field of pharmaceuticals, namely, pharmaceutical research; research and development of products in the field of pharmaceuticals and therapeutics
apexigen

General Information

Serial Number85114062
Word MarkAPEXIGEN
Filing DateMonday, August 23, 2010
Status800 - REGISTERED AND RENEWED
Status DateSaturday, December 31, 2022
Registration Number4165148
Registration DateTuesday, June 26, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2011

Trademark Statements

Goods and Serviceslicensing of intellectual property in the fields of therapeutics and pharmaceuticals
Goods and Servicesconsulting services in the field of pharmaceuticals, namely, pharmaceutical research; research and development of products in the field of pharmaceuticals and therapeutics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 27, 2010
Primary Code042
First Use Anywhere DateFriday, December 3, 2010
First Use In Commerce DateFriday, December 3, 2010
International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 14, 2010
Primary Code045
First Use Anywhere DateFriday, December 3, 2010
First Use In Commerce DateFriday, December 3, 2010

Trademark Owner History

Party NameApexigen, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070
Party NameApexigen, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94070
Party NameApexigen, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94070

Trademark Events

Event DateEvent Description
Saturday, December 31, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Saturday, December 31, 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, December 31, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, December 31, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 14, 2022TEAS SECTION 8 & 9 RECEIVED
Saturday, June 26, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, July 8, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, July 7, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, July 7, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 26, 2018TEAS SECTION 8 & 15 RECEIVED
Monday, June 26, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, June 26, 2012REGISTERED-PRINCIPAL REGISTER
Thursday, May 24, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 23, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Saturday, May 19, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, May 18, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 18, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 18, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 18, 2011NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 18, 2011NON-FINAL ACTION E-MAILED
Friday, November 18, 2011SU - NON-FINAL ACTION - WRITTEN
Friday, October 28, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 27, 2011STATEMENT OF USE PROCESSING COMPLETE
Friday, October 21, 2011USE AMENDMENT FILED
Thursday, October 27, 2011SOU EXTENSION 1 GRANTED
Friday, October 21, 2011SOU EXTENSION 1 FILED
Monday, October 24, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, October 21, 2011TEAS EXTENSION RECEIVED
Friday, October 21, 2011TEAS STATEMENT OF USE RECEIVED
Tuesday, May 3, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 8, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2011PUBLISHED FOR OPPOSITION
Tuesday, February 1, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 1, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 27, 2011PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, January 21, 2011WITHDRAWN FROM PUB - OG REVIEW QUERY
Monday, January 10, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, January 10, 2011ASSIGNED TO LIE
Wednesday, December 15, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 14, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 14, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 14, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 9, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 9, 2010NON-FINAL ACTION E-MAILED
Thursday, December 9, 2010NON-FINAL ACTION WRITTEN
Monday, December 6, 2010ASSIGNED TO EXAMINER
Friday, August 27, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 26, 2010NEW APPLICATION ENTERED

Related Keywords

apexigen pharmaceuticals therapeutics field research namely pharmaceutical products development consulting intellectual